Lilly and EVA Pharma collaborate to deliver insulin.
01
CONTACT US
Book a Meeting
02
ABOUT US
Lilly and EVA Pharma announced a collaboration to deliver a sustainable supply of high-quality, affordable human and analogue insulin to at least one million people, annually, by 2030 who are living with type 1 and type 2 diabetes in low- to middle-income countries.
We empower the fight for health and well being as a human right.
Subscribe for our latest news and updates
For adverse events reporting, please contact us on
PV.Report@evapharma.com
